All articles

145 of 145

Buyer’s guide

How to buy peptides online

A 2026 buyer’s guide — the eight criteria, real price-per-mg ranges by class, the regulatory framing, and a 30-minute vendor verification checklist.

May 22, 2026 14 min read
Tissue & repair

The Wolverine stack, explained

BPC-157 + TB-500 — the most-named peptide stack in the research community. Where the name came from, the mechanistic rationale, and what the evidence actually supports.

May 22, 2026 9 min read
Metabolic / incretin

Where to buy retatrutide

2026 sourcing guide for the triple-agonist landmark — pre-approval framing, the FG-series codename problem, pricing benchmarks, and the CoA red flags specific to GLP-1 class research peptides.

May 22, 2026 8 min read
Tissue & repair

Where to buy BPC-157

2026 research sourcing guide — CAS 137525-51-0, the 503A Category 2 framing, real pricing benchmarks, and the BPC-specific red flags (“Plus”/“Stable” variants, oral/sublingual claims).

May 22, 2026 8 min read
GHRH / Ghrelin

Sermorelin

GHRH 1-29 analog — the 29-aa original used as Geref through 2008. Mechanism, evidence, and modern half-life context.

May 22, 2026 14 min read
Buyer’s guide

Research-grade peptides, explained

What “research grade” means in 2026: HPLC purity floor, ISO 17025 COA, mass-spec identity, and the documentation chain.

May 22, 2026 14 min read
Buyer’s guide

Buying peptides in the USA

USA-specific buyer’s guide — state legality, customs, FDA RUO framework, payment processors, and shipping logistics.

May 22, 2026 14 min read
Buyer’s guide

Peptide prices, explained

Cost-per-mg by class, the 4 levers that drive price, and why cheap peptides should prompt purity questions.

May 22, 2026 13 min read
Metabolic / incretin

Where to buy tirzepatide

Sourcing tirzepatide for research — the 3 channels, pricing across them, and the identity-verification questions to ask.

May 22, 2026 12 min read
Dermal & cosmetic

Where to buy GHK-Cu

GHK-Cu sourcing — copper-complexed vs uncomplexed identity, topical vs injectable evidence, and pricing.

May 22, 2026 10 min read
Buyer’s guide

Best peptide companies (2026)

An 8-criterion evaluation framework — purity, COA transparency, lab partners, returns — applied honestly across vendors.

May 22, 2026 14 min read
Longevity

Where to buy NAD+

NAD+ vs NMN vs NR — identity verification, IV vs oral, and the cofactor-grade purity threshold.

May 22, 2026 10 min read
Tissue & repair

Where to buy TB-500

TB-500 buyer guide — the Tβ4 vs fragment distinction, mass-spec identity, and WADA S2 framing.

May 22, 2026 10 min read
GHRH / Ghrelin

Where to buy CJC-1295

DAC vs no-DAC distinction is critical — mass-spec ID, half-life difference, pricing tiers, and storage stability.

May 22, 2026 10 min read
GHRH / Ghrelin

Where to buy ipamorelin

Ipamorelin sourcing — the Aib residue identity check, selectivity-vs-cost logic, and the CJC-1295 stack context.

May 22, 2026 10 min read
GHRH / Ghrelin

Where to buy tesamorelin

Three channels: Egrifta prescription, 503A compounded, research-grade RUO. Mass-spec on the modified peptide.

May 22, 2026 12 min read
Neuro & sleep

Where to buy PT-141

Bremelanotide sourcing — Vyleesi prescription vs research-grade, MC4R mechanism, melanotan II substitution risk.

May 22, 2026 11 min read
Buyer’s guide

Where to buy bacteriostatic water

0.9% benzyl alcohol bacteriostatic water for peptide reconstitution — USP grade, 28-day stability.

May 22, 2026 7 min read
Longevity

Pinealon

EDR tripeptide, Khavinson school. Russian preclinical work, mitochondrial proposals, thin Western RCT base.

May 22, 2026 11 min read
Longevity

Cartalax

AED tripeptide for cartilage research. Khavinson cytogen — preclinical-strong, RCT-poor.

May 22, 2026 9 min read
Immune

Testagen

KEDG tetrapeptide, Khavinson school. Proposed thymic function support; single-source-dominance flagged.

May 22, 2026 9 min read
Immune

Vilon

KE dipeptide, Khavinson cytogen for immune cell proliferation. Honest evidence-base framing.

May 22, 2026 9 min read
Longevity

Vesugen

KED tripeptide, Khavinson cytogen for vascular research. Thin Western RCT data.

May 22, 2026 9 min read
Metabolic / incretin

Cagrilintide

Long-acting amylin analog. Phase 2 monotherapy 9.7% weight loss; CagriSema combined hits 20.4% in REDEFINE-1.

May 22, 2026 12 min read
Dermal & cosmetic

Argireline

Acetyl Hexapeptide-3 — the “Botox-like” SNAP-25 inhibitor. Topical anti-wrinkle evidence and cosmeceutical regulatory framing.

May 22, 2026 11 min read
Dermal & cosmetic

Matrixyl

Palmitoyl Pentapeptide-4 (KTTKS). Topical collagen-stimulating cosmeceutical with dermatology RCT base.

May 22, 2026 11 min read
Immune

Thymosin Alpha 1 (Tα1)

28-aa Zadaxin/Thymalfasin. 35+ country approval, FDA-unapproved in US. 2025 BMJ TESTS Phase III sepsis negative.

May 22, 2026 13 min read
GHRH / Ghrelin

Gonadorelin (GnRH)

Synthetic GnRH decapeptide. Factrel discontinued; pulsatile-vs-continuous pharmacology, TRT-adjunct off-label.

May 22, 2026 13 min read
GHRH / Ghrelin

Hexarelin

GHRP family — high GH-release potency, tachyphylaxis limitation, cardiac-protection preclinical signal.

May 22, 2026 13 min read
GHRH / Ghrelin

IGF-1 LR3

Long R3 IGF-1 with N-terminal extension. Extended half-life, reduced IGFBP binding — honest cancer-biology framing.

May 22, 2026 13 min read
Longevity

Where to buy MOTS-c

Mitochondrial-derived 16-aa peptide. 12S rRNA identity check, the exercise-mimetic marketing-vs-evidence gap.

May 22, 2026 11 min read
Longevity

Where to buy SS-31

Elamipretide — FDA-approved Forzinity (Sept 2025) for Barth syndrome. 3 channels: prescription, 503A, RUO.

May 22, 2026 13 min read
Longevity

Where to buy Epithalon

AEDG tetrapeptide. Khavinson trials caveats, telomerase activation proposal, identity verification.

May 22, 2026 11 min read
Neuro & sleep

Where to buy Selank

Russian-approved anxiolytic heptapeptide. Tuftsin analog identity, nasal-spray vs injection forms.

May 22, 2026 10 min read
Neuro & sleep

Where to buy Semax

Russian ACTH(4-7) analog for ischemic stroke. Heptapeptide identity check, nasal vs injection.

May 22, 2026 10 min read
Immune

Where to buy KPV

α-MSH C-terminal tripeptide. Anti-inflammatory without pigmentation, oral vs injectable forms for IBD research.

May 22, 2026 10 min read
Longevity

Where to buy glutathione

Master cellular antioxidant tripeptide. IV vs oral vs liposomal, the FDA Philippines IV skin-whitening warning.

May 22, 2026 11 min read
Metabolic / incretin

Where to buy 5-Amino-1MQ

NNMT inhibitor (technically not a peptide). Oral research advantage, honest mouse-only evidence framing.

May 22, 2026 11 min read
Neuro & sleep

Where to buy DSIP

Delta sleep-inducing nonapeptide — the receptor unidentified after 50 years. Sleep claim vs RCT gap.

May 22, 2026 11 min read
Longevity

The mitochondrial stack

SS-31 + MOTS-c + NAD+ — three complementary mitochondrial mechanisms. Zero published controlled human trials of the combination.

May 22, 2026 11 min read
GHRH / Ghrelin

GH-axis triple stack

CJC-1295 + Ipamorelin + Tesamorelin — supra-additive GH release across GHRH + GHRP receptors.

May 22, 2026 11 min read
Neuro & sleep

Selank + Semax cognitive stack

Russian heptapeptide stack — anxiolytic + nootropic. Institute of Molecular Genetics provenance, honest Western RCT framing.

May 22, 2026 10 min read
Metabolic / incretin

AOD-9604

HGH fragment 177-191. Phase IIb obesity trial NEGATIVE — honest framing, FDA GRAS for food not drug approval.

May 22, 2026 12 min read
Metabolic / incretin

Adipotide (FTPP)

Pro-apoptotic peptide targeting adipose vasculature. Phase I kidney toxicity halted development — honest safety framing.

May 22, 2026 12 min read
Buyer’s guide

Are peptides legal in the USA?

Complete legal framework — RUO under 21 CFR §809.10, 503A categories, WADA prohibition, customs, seller-vs-buyer asymmetry.

May 22, 2026 14 min read
Tissue & repair

BPC-157

Complete research guide — identity, multifactorial mechanism, the 35:1 preclinical-to-human ratio, FDA Cat 2 / WADA S0 status.

May 11, 2026 14 min read
Longevity

SS-31 (elamipretide)

Complete research guide — mitochondria-targeted tetrapeptide, FDA-approved for Barth syndrome (Forzinity, Sept 2025).

May 11, 2026 14 min read
Neuro & sleep

PT-141 (bremelanotide)

Complete research guide — FDA-approved melanocortin agonist for HSDD: Vyleesi, the Phase III data, and the off-label dose-response.

May 11, 2026 13 min read
Education

What are peptides? A plain-English introduction

The 50-amino-acid line that separates a peptide from a protein. Why the distinction matters for half-life, synthesis, and oral bioavailability.

May 11, 2026 7 min read
Dermal & cosmetic

GHK-Cu

Complete research guide — endogenous copper tripeptide that declines with age, with the strongest topical signal in the catalog.

May 10, 2026 13 min read
GHRH / Ghrelin

Tesamorelin

Complete research guide — FDA-approved stabilized GHRH analog, the gold standard for the class.

May 10, 2026 14 min read
Metabolic / incretin

Tirzepatide

Complete research guide — FDA-approved dual GIP/GLP-1 agonist: SURMOUNT, SURPASS, and the field-defining weight-loss curves.

May 10, 2026 15 min read
Longevity

SS-31 and the cardiolipin interaction

Selective binding to cardiolipin in the inner mitochondrial membrane — how it preserves cristae structure and ETC efficiency.

May 10, 2026 10 min read
Neuro & sleep

PT-141 and CNS melanocortin signaling

MC4R activation in the hypothalamus — the neural mechanism behind the sexual-arousal effect.

May 10, 2026 10 min read
Immune

KPV

Complete research guide — the C-terminal tripeptide of α-MSH: melanocortin signaling, the cleanest preclinical signal for ulcerative colitis.

May 10, 2026 12 min read
Education

How peptides work in the body

Receptor binding, signal cascades, and the difference between peptide hormones and structural peptides.

May 10, 2026 8 min read
Tissue & repair

BPC-157 — orthopaedic evidence aggregated

First systematic review of 36 studies on BPC-157 for orthopaedic indications. Honest about the human-evidence gap.

May 9, 2026 9 min read
Dermal & cosmetic

GHK-Cu and dermal collagen synthesis

Type I/III procollagen mRNA upregulation in dermal fibroblasts. The biochemical case for topical anti-aging.

May 9, 2026 9 min read
GHRH / Ghrelin

Tesamorelin stabilized-GHRH mechanism

DPP-4 resistance and the structural changes that turn a 30-minute peptide into a once-daily injectable.

May 9, 2026 10 min read
Metabolic / incretin

Tirzepatide dual-agonist mechanism

How a single 39-residue peptide engages two incretin receptors — and why the GIP arm changes the outcome.

May 9, 2026 10 min read
Longevity

SS-31 / Forzinity Barth syndrome FDA approval

Accelerated approval based on the pivotal TAZPOWER + extension data. The first disease-specific therapy for Barth.

May 9, 2026 11 min read
Neuro & sleep

PT-141 / Vyleesi HSDD trials

The pivotal Phase III RECONNECT and PRISM studies — efficacy magnitude, adverse-event profile, and the FDA approval.

May 9, 2026 11 min read
Immune

KPV melanocortin mechanism

MC1R-independent anti-inflammatory action. Why a 3-residue peptide retains the parent molecule’s function.

May 9, 2026 9 min read
Education

Peptide vs. protein: where the line sits

The arbitrary 50-residue threshold, the practical differences, and why the cutoff actually matters in formulation.

May 9, 2026 6 min read
Tissue & repair

BPC-157 and the gut barrier

Where the gut-healing claim actually comes from — VEGF, NO synthase, and dose-response in rodent colitis models.

May 8, 2026 10 min read
Dermal & cosmetic

GHK-Cu skin aging research

RCTs on GHK-Cu topical creams in photoaged skin — wrinkle depth, hydration, elasticity. Effect sizes and study limits.

May 8, 2026 10 min read
GHRH / Ghrelin

Tesamorelin in HIV lipodystrophy

The pivotal RCTs that earned FDA approval — VAT reduction, IGF-1 dynamics, and the long-term safety extension data.

May 8, 2026 11 min read
Metabolic / incretin

SURMOUNT-1: the trial that reset weight loss

NEJM 2022 Phase III in obesity — 22.5% mean body weight reduction at 72 weeks, the highest pharmaceutical figure on record.

May 8, 2026 11 min read
Longevity

SS-31 vs. MOTS-c

Two mitochondrial peptides with different mechanisms. Where the use-cases overlap and where they diverge.

May 8, 2026 9 min read
Neuro & sleep

Semax

Complete research guide — Russian heptapeptide derived from ACTH(4-10): BDNF upregulation and the stroke-recovery indication.

May 8, 2026 13 min read
Immune

KPV in ulcerative colitis models

DSS-induced colitis models, oral and topical formulations, and the dose-response. Human trials still pending.

May 8, 2026 10 min read
Education

How peptides are made: SPPS in plain English

Solid-phase peptide synthesis — the Merrifield method, coupling chemistry, and why HPLC purity matters for the final product.

May 8, 2026 8 min read
Tissue & repair

BPC-157 knee pain case series

Retrospective chart review of 16 patients with intra-articular BPC-157 — phone-recall outcomes only, no controls.

May 7, 2026 7 min read
Dermal & cosmetic

GHK-Cu wound healing evidence

Diabetic ulcer and burn-wound trials. Where the topical formulation reaches and where systemic injection adds nothing.

May 7, 2026 11 min read
GHRH / Ghrelin

Tesamorelin cognition aging trials

Pilot-stage trials in MCI and mild Alzheimer’s — directional cognitive signal, no Phase III evidence yet.

May 7, 2026 10 min read
Metabolic / incretin

Tirzepatide vs. semaglutide

SURMOUNT-5 head-to-head — tirzepatide outperformed semaglutide on weight loss with comparable adverse-event profile.

May 7, 2026 9 min read
Longevity

MOTS-c

Complete research guide — 16-residue mitochondrial-encoded peptide: the "exercise mimetic" claim, the AMPK story, and the human-trial gap.

May 7, 2026 13 min read
Neuro & sleep

Semax ACTH-BDNF mechanism

The ACTH(4-10)Pro-Gly-Pro structure and how it engages BDNF signaling without the corticotropic side-effects of full ACTH.

May 7, 2026 10 min read
Education

How to read a Certificate of Analysis

Identity, purity, endotoxin, microbial, heavy metals. The six tests on every COA — and what the numbers actually mean.

May 7, 2026 7 min read
Tissue & repair

BPC-157 and VEGFR2 angiogenesis

How a 15-residue peptide upregulates VEGFR2 expression and triggers tube formation in endothelial cell assays.

May 6, 2026 11 min read
Dermal & cosmetic

GHK-Cu and the hair follicle

Anagen-phase prolongation in hair-pluck cultures. The case for and against scalp injections vs. topicals.

May 6, 2026 9 min read
GHRH / Ghrelin

CJC-1295

Complete research guide — two molecules share the name: DAC vs. no-DAC half-life, the receptor pharmacology, and the missing human trials.

May 6, 2026 13 min read
Metabolic / incretin

Tirzepatide frequently asked questions

Indication, dosing schedule, GI tolerability, and where the compounded vs. branded distinction matters.

May 6, 2026 8 min read
Longevity

MOTS-c and AMPK activation

How a 16-residue ORF-encoded peptide activates AMPK and modulates the AICAR pathway in muscle.

May 6, 2026 10 min read
Neuro & sleep

Semax stroke recovery research

Russian post-stroke trials show motor-function improvement. Methodological details and the Western-replication gap.

May 6, 2026 11 min read
Education

What "research use only" actually means

The FDA regulatory category, what RUO products can and can’t be sold for, and how the line is enforced.

May 6, 2026 7 min read
Tissue & repair

BPC-157 vs. TB-500

Two different molecules for two different problems. When the literature supports stacking, and when it doesn’t.

May 5, 2026 10 min read
Dermal & cosmetic

GHK-Cu: injectable vs. topical

The route-of-administration debate. Why topical formulations dominate the published literature.

May 5, 2026 8 min read
GHRH / Ghrelin

CJC-1295 GHRH-receptor mechanism

How a GHRH analog with a maleimidopropionyl modification ends up albumin-bound with an 8-day half-life.

May 5, 2026 9 min read
Metabolic / incretin

Retatrutide

Complete research guide — triple GIP/GLP-1/glucagon agonist: the Phase II readout that reset the upper bound of pharmacological weight loss.

May 5, 2026 14 min read
Longevity

MOTS-c as an exercise mimetic

Murine models show insulin sensitization without exercise. The human-extrapolation problem.

May 5, 2026 10 min read
Neuro & sleep

Selank

Complete research guide — Russian heptapeptide derived from tuftsin: GABAergic modulation, anti-anxiety claims, and the trial-quality picture.

May 5, 2026 12 min read
Education

Bacteriostatic water: a reconstitution guide

Why benzyl alcohol matters, the standard 0.9% formulation, and where bacteriostatic water replaces sterile water in laboratory protocols.

May 5, 2026 6 min read
Tissue & repair

BPC-157 frequently asked questions

Reconstitution, half-life, route of administration, and what the literature does and doesn’t say about safety.

May 4, 2026 7 min read
Dermal & cosmetic

Copper peptides in tallow-based formulations

Carrier choice matters. How tallow, ceramide, and aqueous bases change the GHK-Cu delivery profile.

May 4, 2026 8 min read
GHRH / Ghrelin

CJC-1295 vs. ipamorelin

Different receptors, different pulse patterns. Why the "stack" became the dominant grey-market combination.

May 4, 2026 9 min read
Metabolic / incretin

Retatrutide triple-agonist mechanism

GIP + GLP-1 + glucagon receptor engagement. Why adding the glucagon arm changes the energy-balance math.

May 4, 2026 11 min read
Longevity

NAD+

Complete research guide — IV infusion, NMN, NR, NAM: the four ways to address declining cellular NAD+ and what the data actually supports.

May 4, 2026 14 min read
Neuro & sleep

Selank tuftsin-GABAergic mechanism

How a stabilized tuftsin analog modulates GABA-A receptor expression and reduces anxiety-related behavior in models.

May 4, 2026 9 min read
Education

Peptide reconstitution: a step-by-step guide

From lyophilized vial to working solution — concentration math, swirl-don’t-shake, and storage windows for the most common SKUs.

May 4, 2026 8 min read
Tissue & repair

The BPC-157 + TB-500 blend, evaluated

The most-stacked combination in research peptides. What the additive-mechanism case looks like and where it falls apart.

May 3, 2026 9 min read
Dermal & cosmetic

Glutathione

Complete research guide — the master endogenous antioxidant: redox cycling, IV vs. oral controversy, and the skin-lightening evidence base.

May 3, 2026 14 min read
GHRH / Ghrelin

CJC-1295 vs. tesamorelin

Both are stabilized GHRH analogs. Why one is FDA-approved and the other isn’t.

May 3, 2026 9 min read
Metabolic / incretin

Retatrutide Phase 2: trial deep-dive

24.2% body-weight reduction at 48 weeks (NEJM 2023). The setup for the Phase III readouts in progress.

May 3, 2026 12 min read
Longevity

NAD+ and the sirtuin pathway

SIRT1-7 deacetylase dependence on NAD+. The mechanism that anchors most of the "anti-aging" claims for the molecule.

May 3, 2026 10 min read
Neuro & sleep

Selank anxiety trials

Russian GAD trials — anxiolytic effect in 60–80% of cohorts, but limited blinding and small sample sizes.

May 3, 2026 10 min read
Education

Peptide storage & stability

Frozen vs. refrigerated vs. room-temperature stability windows. Lyophilized vial life, post-reconstitution life, and freeze-thaw cycle limits.

May 3, 2026 8 min read
Tissue & repair

BPC + TB-500: stacking mechanism

VEGF-driven angiogenesis (BPC-157) + actin-monomer-driven cell migration (TB-500). Where the mechanisms converge.

May 2, 2026 11 min read
Dermal & cosmetic

Glutathione redox cycling

GSH/GSSG ratio, glutathione peroxidase, and why "supplementing antioxidants" isn’t the same as raising cellular GSH.

May 2, 2026 10 min read
GHRH / Ghrelin

CJC-1295 + ipamorelin stack research

The published evidence on the CJC + ipamorelin combination — what’s actually been tested vs. claimed.

May 2, 2026 10 min read
Metabolic / incretin

Retatrutide vs. tirzepatide

Two pharmaceutical heavyweights compared. Where the dose-response curves diverge.

May 2, 2026 9 min read
Longevity

NAD+: IV vs. oral precursors

IV NAD+, NMN, NR, NAM. Bioavailability, tissue distribution, and where the head-to-head trials land.

May 2, 2026 10 min read
Neuro & sleep

Selank vs. Semax

Both Russian-school nootropics. Different parent peptides, different receptor targets, different use-cases.

May 2, 2026 9 min read
Education

Peptide half-life, explained

Why some peptides last 30 minutes and others last 8 days. DPP-4 cleavage, albumin binding, and structural modifications.

May 2, 2026 8 min read
Tissue & repair

TB-500

Complete research guide — thymosin-β4 (1-43 fragment), actin binding, cell migration, and the cardiac-repair preclinical signal.

May 1, 2026 13 min read
Dermal & cosmetic

Glutathione skin-lightening evidence

A class of trials with positive descriptive findings but persistent methodological holes — and an FDA warning letter on IV use.

May 1, 2026 11 min read
GHRH / Ghrelin

Ipamorelin

Complete research guide — the selective ghrelin-receptor agonist: the GH peptide that doesn’t spike cortisol or prolactin.

May 1, 2026 12 min read
Metabolic / incretin

CagriSema REDEFINE-1 readout

Cagrilintide + semaglutide fixed-dose combination. 20.4% mean weight loss at 68 weeks — the largest pharmacological figure documented.

May 1, 2026 9 min read
Longevity

Epithalon

Complete research guide — Russian tetrapeptide aging program: Khavinson’s 1971 work, the telomerase claims, and the methodological gaps Western labs flagged.

May 1, 2026 13 min read
Neuro & sleep

DSIP

Complete research guide — delta sleep-inducing peptide: 1977 isolation, the sleep-architecture claim, and the trial-quality gap.

May 1, 2026 12 min read
Education

Peptide injection routes, compared

Subcutaneous, intramuscular, intravenous, intra-articular. Which routes the published research actually uses for which peptides.

May 1, 2026 9 min read
Tissue & repair

TB-500 actin-binding mechanism

The G-actin sequestration model — how Tβ4 controls the actin monomer pool and modulates cell motility.

Apr 30, 2026 9 min read
Dermal & cosmetic

Skin & cosmetic peptides: class overview

The class-level landscape. Where the topical evidence is real (GHK-Cu) and where it isn’t (most else).

Apr 30, 2026 8 min read
GHRH / Ghrelin

Ipamorelin GHS-R mechanism

Growth hormone secretagogue receptor pharmacology — why ipamorelin is more selective than GHRP-2 or hexarelin.

Apr 30, 2026 9 min read
Metabolic / incretin

GLP-1 class comparison: 2026

Semaglutide, tirzepatide, retatrutide, mazdutide, cagrisema. The current state of the class, by trial readout.

Apr 30, 2026 11 min read
Longevity

Epithalon telomerase mechanism

The pineal-telomerase upregulation hypothesis. What’s replicated, what isn’t, and what stays unfalsifiable.

Apr 30, 2026 9 min read
Neuro & sleep

DSIP and delta-wave EEG

The slow-wave-sleep induction hypothesis — what the EEG data actually shows and where it doesn’t replicate.

Apr 30, 2026 9 min read
Education

Peptide purity: HPLC, explained

How reverse-phase HPLC measures peptide purity, why 95% vs. 99% matters, and what the 220 nm chromatogram is actually showing you.

Apr 30, 2026 8 min read
Tissue & repair

TB-500 cardiac repair research

Murine MI models show Tβ4-driven epicardial reactivation. Human Phase II hit the primary endpoint; Phase III is pending.

Apr 29, 2026 11 min read
GHRH / Ghrelin

GH-axis peptides: class overview

Tesamorelin (FDA-approved), CJC-1295, ipamorelin, sermorelin, hexarelin. The full landscape, in tiers.

Apr 29, 2026 9 min read
Metabolic / incretin

GLP-1 class peptides: overview

How the GLP-1 receptor agonists got from exendin-4 to triple agonists — and where the class is going next.

Apr 29, 2026 10 min read
Longevity

Epithalon Russian aging trials

Multi-decade Russian elderly-cohort trials. Survival, T-cell parameters, and the methodological limits of the data.

Apr 29, 2026 11 min read
Neuro & sleep

DSIP stress and cortisol research

Cortisol-suppression trials in chronic stress cohorts. Endpoint definitions, sample sizes, and study limits.

Apr 29, 2026 10 min read
Education

COA vs. MSDS: what’s the difference?

Two documents, two purposes. The Certificate of Analysis grades the product; the Safety Data Sheet covers handling.

Apr 29, 2026 6 min read
Tissue & repair

Tissue repair peptides: class overview

BPC-157, TB-500, and the BPC/TB blend. The class-level evidence picture and how the molecules differ.

Apr 28, 2026 8 min read
Longevity

5-Amino-1MQ

Complete research guide — selective NNMT inhibitor: the murine fat-loss signal, the mechanism, and the absent human trials.

Apr 28, 2026 12 min read
Neuro & sleep

Sleep & recovery peptides: overview

DSIP, semax, selank, ipamorelin. Where the sleep-architecture claims have data and where they don’t.

Apr 28, 2026 9 min read
Education

ISO 17025: what the accreditation actually means

The international standard for testing-lab competence. Why accredited labs carry it, and what it changes about COA credibility.

Apr 28, 2026 8 min read
Longevity

5-Amino-1MQ NNMT inhibition

Nicotinamide N-methyltransferase inhibition shifts the methyl-donor balance. The energy-expenditure case.

Apr 27, 2026 9 min read
Neuro & sleep

Cognitive peptides: the Russian school

A history of Russian neuropeptide research — tuftsin, ACTH(4-10), and the molecules that didn’t cross the Western methodological bar.

Apr 27, 2026 11 min read
Education

Peptide "stack protocols": what the evidence actually says

A walk through the most-cited stacks (BPC+TB, CJC+ipamorelin) — what’s been tested, what’s extrapolated, and what’s pure marketing.

Apr 27, 2026 10 min read
Longevity

5-Amino-1MQ fat-loss research

High-fat-fed mouse models show body-weight reduction without locomotor change. Sample size, dose, and translation limits.

Apr 26, 2026 10 min read
Education

The 2023 FDA 503A peptide ruling

What changed when the FDA shifted several peptides out of 503A compounding eligibility — and what it meant for the grey market.

Apr 26, 2026 9 min read
Longevity

Mitochondrial peptides: class overview

SS-31, MOTS-c, humanin, and the ORF-encoded peptide class. The state of the field as of 2026.

Apr 25, 2026 9 min read
Education

WADA prohibited list 2026: peptide entries

Which peptides sit on the WADA prohibited list, which categories they fall under, and the in-competition vs. out-of-competition distinction.

Apr 25, 2026 8 min read